MYRIAD GENETICS (MYGN) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
MYRIAD GENETICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $722K and 1 sold $67K of MYGN stock on the open market.
Get emailed when insiders cluster-buy stocks like MYGN
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
MYGN insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $28K | 1 | $67K | 1 |
| Q1 2026 | $695K | 4 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 3 MYRIAD GENETICS INC insiders reported open-market purchases totaling $722K, while 1 insider reported sales totaling $67K. Among insiders with enough purchase history to measure, S. Louise Phanstiel (Director) has the highest Insider Score at 63. 1 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jun 9SEC | Rashmi KumarDirector | Sell Plan | 15,000171,889 held (−8%) | $4.46 | $67K | -3.4% | — |
| May 14SEC | Paul BisaroDirector | Buy | 7,50097,441 held (+8%) | $3.69 | $28K | +16.8% | 37 |
| Mar 9SEC | Samraat S. RahaCEO, President | Buy | 40,000493,104 held (+9%) | $5.00 | $200K | -13.8% | — |
| Feb 27SEC | S. Louise PhanstielDirector | Buy | 50,407233,951 held (+27%) | $4.80 | $242K | -10.2% | 63 |
| Feb 27SEC | S. Louise PhanstielDirector | Buy | 48,000281,951 held (+21%) | $4.66 | $224K | -7.5% | 63 |
| Feb 27SEC | S. Louise PhanstielDirector | Buy | 6,100183,544 held (+3%) | $4.74 | $29K | -9.1% | 63 |
Insiders at MYRIAD GENETICS INC
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| S. Louise PhanstielDirector | $495K | — | Feb 27, 2026 | 63 |
| Samraat S. RahaCEO, President | $200K | — | Mar 9, 2026 | — |
| Paul BisaroDirector | $28K | — | May 14, 2026 | 37 |
| Rashmi KumarDirector | — | $67K | Jun 9, 2026 | — |
MYGN stock: common questions
Are MYRIAD GENETICS INC insiders buying MYGN stock?
In the past 12 months, 3 insiders reported open-market purchases of MYGN worth $722K. The latest was Director Paul Bisaro bought $28K of MYGN at $3.69 — first open-market purchase in our records.
Are MYRIAD GENETICS INC insiders selling MYGN stock?
1 insiders reported sales worth $67K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is MYGN's 52-week range?
Over the past year MYGN has traded between $2.86 and $8.18. It last closed at $4.31 on Oct 9, 2026.